Zeiss Receives CE Mark Approval for PLEX Elite 9000 Swept-Source OCT

Source: Carl Zeiss Meditec

Monday, May 02, 2016 | CE Mark Approval , Product Releases , , Carl Zeiss Meditec


Zeiss announced that it has received CE Mark approval for its new swept-source OCT technology platform, Zeiss PLEX Elite 9000. The new platform expands researchers’ ability to examine the critical retinal microstructures and microvasculature of the eye at any depth of interest (e.g. vitreous, retina and choroid) by providing OCT and OCT Angiography imaging that is fast, dense, wide and deep – with visualization previously not possible with other technologies, according to a company news release.

PLEX Elite 9000 Swept-Source OCT is the latest and most advanced OCT innovation from Zeiss. This technology allows clinical researchers the potential to see deeper, wider and in more detail from the vitreous to the sclera in the posterior segment. The platform offers researchers the potential to assess early mechanisms for micro- and neo-vascularization, to explore the predictors of progression of retinal and choroidal pathology, to deepen the understanding of choroid physiopathology, and to evaluate mechanisms of retina and choroid response to therapy.

The PLEX Elite 9000 from Zeiss is being introduced byt the Advanced Retina Imaging network during the Association for Research in Vision and Ophthalmology (ARVO) annual meeting May 1-6, 2016 in Seattle.

The Advanced Retina Imaging network is a unique global consortium of scientists from around the world working at the forefront of retinal disease research. Participating researchers will have access to the most up-to-date Zeiss technology and the opportunity to collaborate with peers in the network and with Zeiss. Each PLEX Elite imaging system in the network is maintained at the cutting edge with iterative hardware and software upgrades. Researchers are supported with an assigned Zeiss scientific liaison who will respond to technology needs for specific investigations, according to the news release.


Comments

You must be logged in to leave a comment.